A carregar...

Determining Duration of HER2-Targeted Therapy Using Stem Cell Extinction Models

INTRODUCTION: Trastuzumab dramatically improves survival in breast cancer patients whose tumor overexpresses HER2. A subpopulation of cells in human breast tumors has been identified with characteristics of cancer stem cells. These breast cancer stem-like cells (BCSCs) rely on HER2 signaling for sel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Riley, Lindsay, Zhou, Hua, Lange, Kenneth, Sinsheimer, Janet S., Sehl, Mary E
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3532453/
https://ncbi.nlm.nih.gov/pubmed/23284608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0046613
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!